BioCentury
ARTICLE | Emerging Company Profile

Vasomune: Lassoing Tie2

Vasomune's vasculotide activates Tie2 to treat acute kidney injury

October 27, 2014 7:00 AM UTC

Agonizing Tie2 could restore vascular integrity and limit tissue damage in kidney injury, but bringing together the four copies needed to activate the receptor is a job too big for small molecules or antibodies. Vasomune Therapeutics Inc. has shown its four-armed peptidomimetic, vasculotide, activates Tie2 and restores vascular integrity in mouse models.

"Many renal diseases are ultimately characterized by a loss in vascular integrity that damages tubules in the kidney," CEO Parimal Nathwani said. "Our idea is to use vasculotide to fix the problem and restore normal vascular integrity before it gets out of control."...